EBD Group is part of the KNect365 of Informa PLC


This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa
Partnerships in Cell and Gene Therapy Partnerships in Cell and Gene Therapy Partnerships in Cell and Gene Therapy Partnerships in Cell and Gene Therapy
Share/Follow Us
Share this:
Follow this event:
Subscribe to our newsletters:

Partnerships in Cell and Gene Therapies Press Releases



partnering360:Insight Latest headlines from partnering360:Insight

January 13, 2017 Consumer products give new life to pharma The relevance of the consumer isn’t a new condition, but the role consumers play as companies make product development decisions may be. more ►

January 13, 2017 The overflowing buffet of immuno-oncology therapeutics: Even more opportunities abound “Immunologists haven’t paid much attention to cancer. They focused on infectious agents. Cancer biologists focused on genetics. IO fell between the cracks. Now that it’s showing results, there’s a backlog of understanding. We are, essentially, trying to build the plane while we’re flying it.” more ►

January 13, 2017 Who gets funded? Imaginative companies! The biotech industry needs a new approach that approximates the type of disruption that Uber brought to transportation and Amazon and eBay brought to retail sales. Instead of embracing those lean models, healthcare is overloaded with middlemen. more ►

January 11, 2017 Rare diseases, rare commitment Patients, their families and patient foundations are invaluable in helping drug developers understand the day-to-day realities of approx. 7,000 rare diseases (of which only 400 have therapies). Without that connection with patients, there is no chance of developing possible cures. more ►

January 11, 2017 Digital medicine: Invest in innovation It’s too soon to say, definitively, whether digital medicine will be disruptive or adjunctive for drug developers or even the entire healthcare system. Even the business models are in flux. What is known, however, is that billions of dollars of deals involving digital medicine were signed in 2016, and that big pharma gradually is becoming involved. more ►



Arrow Up

Follow this event:
Home | Contact Us | Site Map
See more upcoming conferences ►

EBD Group's Family of Events

© 2009–2016 EBD Group
Privacy Policy and Cookies
Terms of Use